Preemption Videos
Click on the photos below to learn more about preemption, and the drug shield law that could deprive injured patients of their legal rights.
Actor Dennis Quaid testifies before a House Oversight Committee hearing on the role that lawsuits play in helping to keep the public safe from dangerous drugs and medical devices.
.
Rep. Bruce Braley (D-IA) grills a representative of the FDA on the agency’s authority to preempt drug liability cases and whether the agency has that power under the Constitution.
.
Rep. Henry Waxman (D-CA) discusses how drug companies would have no incentive to monitor whether their products are safe if the FDA is given the power to preempt lawsuits filed by injured patients.
.
Rep. Bruce Braley (D-IA) questions the assertion that all drugs approved by the FDA are safe for the public, based on the high number of injuries reported by users of some defective drugs and medical devices.
.
Rep. Henry Waxman (D-CA) discusses the problems that result when an FDA-approved drug that has been put on the market turns out not to be safe, leading to serious injuries or death.
.
Rep. Henry Waxman (D-CA) discusses why the FDA lacks the resources to monitor all potentially unsafe drugs and devices, and why these products could seriously harm consumers if the agency were to preempt certain lawsuits.
.
Rep. Bruce Braley (D-IA) questions the editor of the New England Journal of Medicine on how preemption would undermine the effort to protect the safety of those who may be put at risk by dangerous drugs and devices.
.
Rep. Henry Waxman (D-CA) questions David Vladeck of Georgetown University on how the FDA is failing to effectively enforce drug safety, putting the public health at risk.
.
Rep. Henry Waxman (D-CA) questions a panel of experts on how the threat of lawsuits provides an additional incentive for companies to makes drugs and medical devices safer for the public.
.
Republican Christine Ruther testifies before Congress on why the threat of lawsuits ensures that drug and device manufactures take the necessary safety measures to guarantee that their products are safe and effective.
.
Dr. Gregory Curfman, editor of the New England Journal of Medicine, testifies before Congress that preemption of lawsuits by injured patents will result in making drugs and medical devices less safe for the public.
.
David Vladek of Georgetown University testifies before Congress on why preemption would give consumers “the worst of both possible worlds” by exposing them to dangerous drugs and medical devices.
.
Rep. Stephen Lynch (D-MA) discusses the responsibility of drug and device manufacturers to ensure the safety of their products and protect consumers from injuries caused by defects.
.
Actor Dennis Quaid testifies on how financial conflicts of interest involving drug companies and the FDA undermine the agency’s ability to test the safety of new drugs and medical devices.
.
Rep. Diane Watson (D-CA) questions Harvard’s Dr. Aaron Kesselheim on how Merck concealed the dangers of Vioxx from the public, and how these dangers would not have come to light without lawsuits.
.
Rep. Bruce Braley (D-IA) questions a Congressional panel of medical experts on how the burden of paying for the damage caused by defective drugs and medical devices will fall on the average consumer.
.
Former FDA Commissioner David Kessler testifies before Congress on why the FDA system of drug regulation is inadequate for protecting the public from dangerous drugs and medical devices.
.
Dr. Aaron Kesselheim testifies before Congress on the role that lawsuits play in protecting the public when manufacturers hide or fail to disclose the risks of dangerous drugs or medical devices.
.
Dr. William Maisel of Beth Israel Deaconess Medical Center explains how financial conflicts and problems at the FDA in keeping dangerous drugs off the market may jeopardize the public health.
.
Rep. Henry Waxman (D-CA) discusses the dangerous consequences for consumers that would result if the FDA were given the power to preempt lawsuits against the manufacturers of dangerous drugs and devices.